Your browser is no longer supported. Please, upgrade your browser.
Settings
LCI Lannett Company, Inc. daily Stock Chart
LCI [NYSE]
Lannett Company, Inc.
Index- P/E- EPS (ttm)-7.26 Insider Own7.90% Shs Outstand41.16M Perf Week6.06%
Market Cap482.81M Forward P/E7.29 EPS next Y1.61 Insider Trans1.32% Shs Float31.44M Perf Month-12.53%
Income-272.10M PEG- EPS next Q0.19 Inst Own99.90% Short Float48.79% Perf Quarter39.31%
Sales655.40M P/S0.74 EPS this Y-839.10% Inst Trans-0.89% Short Ratio6.69 Perf Half Y62.47%
Book/sh8.81 P/B1.33 EPS next Y28.18% ROA-21.80% Target Price10.50 Perf Year184.02%
Cash/sh- P/C- EPS next 5Y15.00% ROE-83.00% 52W Range3.33 - 15.52 Perf YTD136.49%
Dividend- P/FCF3.18 EPS past 5Y-45.10% ROI-17.70% 52W High-24.42% Beta2.21
Dividend %- Quick Ratio1.90 Sales past 5Y19.10% Gross Margin37.20% 52W Low252.25% ATR0.81
Employees1020 Current Ratio2.70 Sales Q/Q-21.70% Oper. Margin-40.10% RSI (14)54.20 Volatility5.03% 5.85%
OptionableYes Debt/Eq2.18 EPS Q/Q20.30% Profit Margin-41.50% Rel Volume0.30 Prev Close11.95
ShortableYes LT Debt/Eq1.98 EarningsNov 26 AMC Payout- Avg Volume2.29M Price11.73
Recom3.00 SMA20-0.79% SMA5012.06% SMA20047.08% Volume688,623 Change-1.84%
Mar-20-19Initiated SunTrust Hold
Aug-20-18Downgrade ROTH Capital Buy → Neutral
Aug-20-18Downgrade Raymond James Outperform → Mkt Perform
Jan-24-18Initiated Goldman Neutral
Jun-29-16Initiated Deutsche Bank Hold $26
Mar-24-16Downgrade Canaccord Genuity Buy → Sell $28 → $18
Feb-04-16Upgrade Craig Hallum Hold → Buy
Nov-05-15Downgrade Craig Hallum Buy → Hold
Sep-03-15Reiterated ROTH Capital Buy $61 → $68
Jul-21-15Initiated Susquehanna Positive
Feb-05-15Reiterated ROTH Capital Buy $54 → $61
Nov-24-14Reiterated ROTH Capital Buy $66 → $60
Nov-04-14Reiterated ROTH Capital Buy $53 → $66
Nov-04-14Reiterated Canaccord Genuity Buy $55 → $73
Nov-04-14Downgrade Oppenheimer Outperform → Perform $53
Oct-13-14Reiterated Oppenheimer Outperform $51 → $53
Jul-15-14Reiterated Oppenheimer Outperform $49 → $52
May-06-14Resumed Canaccord Genuity Buy $55
Feb-10-14Reiterated Canaccord Genuity Buy $29 → $55
Feb-07-14Reiterated Oppenheimer Outperform $41 → $45
Oct-18-19 05:45PM  Lannett (LCI) Dips More Than Broader Markets: What You Should Know Zacks
11:22AM  The Zacks Analyst Blog Highlights: NRG Energy, Lannett Company, Genesis Healthcare, US Foods and Grocery Outlet Zacks
Oct-17-19 08:03AM  Buy These 5 Defensive Stocks to Counter Market Volatility Zacks
Oct-08-19 05:50PM  Lannett (LCI) Stock Moves -0.9%: What You Should Know Zacks
Oct-07-19 09:30AM  Is Lannett Co (LCI) Stock Outpacing Its Medical Peers This Year? Zacks
Oct-04-19 10:00PM  Bragar Eagel & Squire is Investigating Certain Officers and Directors of Lannett Company, LogMeIn, and Mammoth Energy and Encourages Investors to Contact the Firm GlobeNewswire
Oct-01-19 09:13AM  Top Ranked Momentum Stocks to Buy for October 1st Zacks
06:52AM  Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS® PR Newswire
Sep-27-19 04:15PM  Lannett Announces Closing Of $86.25 Million Of Convertible Senior Notes Due 2026 PR Newswire
Sep-25-19 09:20AM  Will Lannett Continue to Surge Higher? Zacks -17.48%
07:40AM  Lannett Announces pricing of $75 million of Convertible Senior Notes Due 2026 PR Newswire
Sep-24-19 04:15PM  Lannett Announces Offering of $75 million of Convertible Senior Notes Due 2026 PR Newswire
Sep-20-19 10:00AM  Lannett (LCI) is a Great Momentum Stock: Should You Buy? Zacks
Sep-19-19 02:38PM  Should You Take Comfort From Insider Transactions At Lannett Company, Inc. (NYSE:LCI)? Simply Wall St.
10:42AM  Top Ranked Momentum Stocks to Buy for September 19th Zacks
Sep-16-19 07:42AM  Moving Average Crossover Alert: Lannett Company Zacks
Sep-13-19 08:24AM  Ardelyx (ARDX) in Focus: Stock Moves 8.3% Higher Zacks
Sep-11-19 10:13AM  Small Drug Stock Outlook: Innovation Holds the Key to Growth Zacks +13.25%
Sep-09-19 10:36AM  Edited Transcript of LCI earnings conference call or presentation 27-Aug-19 8:30pm GMT Thomson Reuters StreetEvents -9.12%
07:31AM  Abrams plans indoor 'farming' in former Lannett building in Northeast Philadelphia American City Business Journals
Sep-04-19 09:15AM  Lannett (LCI) Hits 52-Week High, Can the Run Continue? Zacks
Sep-03-19 10:47AM  Is the Options Market Predicting a Spike in Lannett (LCI) Stock? Zacks
Aug-29-19 11:59AM  A Look At Benzinga Pro's Most-Searched Tickers For August 29, 2019 Benzinga +9.63%
09:50AM  Ensign Group to Spin Off Home Health & Hospice Business Zacks
08:44AM  Catalyst Pharmaceuticals (CPRX) Looks Good: Stock Adds 6% in Session Zacks
Aug-28-19 12:51PM  Here's Why Lannett Stock Is Soaring Today Motley Fool +34.33%
12:36PM  Lannett Company News: Why LCI Stock Is Skyrocketing Today InvestorPlace
12:32PM  BMO Says 'Questions Still Remain' About Lannett Following Earnings Pop Benzinga
09:50AM  Why Lannett's stock opened up 36% this morning American City Business Journals
07:06AM  Lannett stock soars 34% on news to be exclusive distributor of Posaconazole delayed-release tablets in the U.S. MarketWatch
06:52AM  Lannett Enters Into Distribution Agreement For Posaconazole Delayed-Release Tablets; Launch To Commence Shortly PR Newswire
04:18AM  [video]Lannett to Be U.S. Distributor of Posaconazole Delayed-Release Tablets TheStreet.com
Aug-27-19 10:23PM  Lannett Inc (LCI) Q4 2019 Earnings Call Transcript Motley Fool
09:30PM  What You Need to Know About Lannett's Great Q4 Results Motley Fool
05:45PM  Lannett (LCI) Tops Q4 Earnings and Revenue Estimates Zacks
04:15PM  Lannett Announces Fiscal 2019 Fourth-Quarter, Full-Year Financial Results; Issues Guidance For Fiscal 2020 PR Newswire
07:36AM  Q4 Earnings Outlook For Lannett Benzinga
06:52AM  Lannett Enters Into Advisory Services Agreement With Strategic Alliance Partner PR Newswire
Aug-20-19 10:30AM  Earnings Preview: Lannett (LCI) Q4 Earnings Expected to Decline Zacks
06:52AM  Lannett To Report Fiscal 2019 Fourth-Quarter, Full-Year Financial Results, Host Conference Call On Tuesday, August 27 PR Newswire
Aug-14-19 09:02PM  Bragar Eagel & Squire is Investigating Certain Officers and Directors of Lannett, Molson Coors, AxoGen, and American Renal Associates and Encourages Investors to Contact the Firm GlobeNewswire
Aug-01-19 04:15PM  Lannett Appoints John Kozlowski CFO PR Newswire -7.07%
Jul-25-19 05:45PM  Robbins Arroyo LLP: Shareholder Class Action Against Lannett Company (LCI) Survives Motion to Dismiss Business Wire -5.84%
Jul-22-19 05:49PM  Lannett Company (LCI) Stock Makes the Street Go Wild SmarterAnalyst +40.80%
03:46PM  UPDATE: Lannett stock up 40% with no news released; short interest stands at 74% of float MarketWatch
Jul-19-19 03:50AM  SHAREHOLDER ALERT: Shareholder Class Action Against Lannett Company (LCI) Survives Motion to Dismiss; The Law Offices of Timothy L. Miles Encourages Shareholders to Contact the Firm ACCESSWIRE +6.41%
Jul-16-19 01:42PM  Option Trader Makes Bullish Bet On Lannett Rebound Benzinga
Jul-08-19 06:52AM  Lannett Enters Into Distribution Agreement For Levothyroxine PR Newswire
Jul-03-19 12:02PM  FDA rules in favor of Lannett in dispute over cocaine product American City Business Journals
06:52AM  FDA Clears Path For The Continuing Review Of Lannett Company's New Drug Application PR Newswire
Jun-28-19 06:10PM  Heres What Hedge Funds Think About Lannett Company, Inc. (LCI) Insider Monkey
06:54AM  Lannett Enters Into Distribution Agreement For Dantrolene Capsules, Commences Product Launch PR Newswire
Jun-18-19 06:52AM  Lannett Launches Aspirin And Extended-Release Dipyridamole Capsules PR Newswire
Jun-12-19 06:52AM  Lannett To Participate At Two Investor Conferences In June PR Newswire
Jun-05-19 02:14PM  Lannett initiates human testing of biosimilar insulin product American City Business Journals
06:52AM  Lannett Announces Initiation Of Human Clinical Trial Of Biosimilar Insulin Glargine Versus Us Lantus® PR Newswire
May-30-19 07:07PM  Lifshitz & Miller LLP Announces Investigation of A.O. Smith Corporation, Cray Inc., electroCore, Inc., Fred's Inc., Intersect ENT, Inc., Jumia Technologies AG, Lannett Company Inc., and Zayo Group Holdings, Inc. PR Newswire
May-29-19 06:54AM  Lannett Commences Marketing Generic Concerta® PR Newswire
May-24-19 06:52AM  Lannett Announces CFO Retirement PR Newswire -7.06%
May-23-19 04:08PM  (LCI) Alert: Johnson Fistel, LLP Announces Investigation of Lannett Company, Inc.; Long Term Investors Encouraged to Contact Firm PR Newswire
06:52AM  Lannett Appoints Melissa V. Rewolinski, PhD, To Board Of Directors PR Newswire
May-21-19 09:00AM  Haeggquist & Eck Investigates Conspiracy to Fix Prices on Generic Drugs by Lannett Officers and Directors Business Wire
06:52AM  Lannett Purchases Additional $30.5 Million Of Term A Loans PR Newswire
May-20-19 09:30AM  Is Lannett Co (LCI) Outperforming Other Medical Stocks This Year? Zacks
May-17-19 07:47PM  Robbins Arroyo LLP: Shareholder Class Action Against Lannett Company (LCI) Survives Motion to Dismiss Business Wire
08:52AM  Implied Volatility Surging for Lannett (LCI) Stock Options Zacks
May-16-19 07:42PM  Bragar Eagel & Squire, P.C. is Investigating Lannett Company, Inc. (NYSE: LCI) on Behalf of Lannett Stockholders and Encourages Lannett Investors to Contact the Firm GlobeNewswire
11:09AM  Top Ranked Value Stocks to Buy for May 16th Zacks
06:52AM  Lannett Begins Marketing Generic Adderall® PR Newswire
May-14-19 10:17AM  Here's Why Generic-Drug Manufacturers Were Down Monday Motley Fool
May-13-19 05:49PM  LANNETT INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lannett Company, Inc. To Contact The Firm PR Newswire -19.10%
May-10-19 01:50AM  Edited Transcript of LCI earnings conference call or presentation 6-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-08-19 12:03PM  Lannett gets notice that probe into alleged generic drug price-fixing may widen American City Business Journals -6.38%
May-07-19 04:17PM  SHAREHOLDER ALERT: Investigation of Lannett Announced by Holzer & Holzer, LLC Business Wire -15.42%
12:48PM  Here's Why Lannett Company Stock Is Collapsing Today Motley Fool
May-06-19 08:55PM  Lannett Inc (LCI) Q3 2019 Earnings Call Transcript Motley Fool +6.32%
07:45PM  Lannett (LCI) Surpasses Q3 Earnings and Revenue Estimates Zacks
06:40PM  Lannett: Fiscal 3Q Earnings Snapshot Associated Press
04:15PM  Lannett Announces Fiscal 2019 Third-Quarter Financial Results; Raises Guidance For Fiscal 2019 PR Newswire
09:18AM  Lannett Q3 Earnings Preview Benzinga
May-02-19 09:30AM  Is Lannett Co (LCI) Stock Outpacing Its Medical Peers This Year? Zacks
Apr-30-19 12:23PM  Lannett to launch generic ADHD drug this quarter American City Business Journals
06:52AM  Lannett To Launch Generic Concerta®, AB-rated Methylphenidate Hydrochloride ER Tablets PR Newswire
Apr-29-19 10:31AM  Analysts Estimate Lannett (LCI) to Report a Decline in Earnings: What to Look Out for Zacks
09:15AM  Zoetis (ZTS) Hits Fresh High: Is There Still Room to Run? Zacks
06:52AM  Lannett To Report Fiscal 2019 Third-Quarter Financial Results, Host Conference Call On Monday, May 6 PR Newswire
Apr-24-19 04:45PM  Lannett (LCI) to Report Q3 Earnings: What's in the Cards? Zacks
Apr-16-19 03:02PM  Investors Who Bought Lannett Company (NYSE:LCI) Shares Five Years Ago Are Now Down 77% Simply Wall St.
08:43AM  Are Options Traders Betting on a Big Move in Lannett (LCI) Stock? Zacks
Apr-12-19 05:45PM  Lannett (LCI) Gains But Lags Market: What You Should Know Zacks
Apr-08-19 09:30AM  Has Lannett Co (LCI) Outpaced Other Medical Stocks This Year? Zacks
Apr-04-19 05:45PM  Lannett (LCI) Stock Sinks As Market Gains: What You Should Know Zacks
Mar-28-19 05:45PM  Lannett (LCI) Outpaces Stock Market Gains: What You Should Know Zacks
Mar-27-19 06:52AM  Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg PR Newswire +5.36%
Mar-26-19 07:21AM  New Strong Buy Stocks for March 26th Zacks
Mar-21-19 06:54AM  Lannett Purchases $24 Million Of Term Loans In Open Market Transactions PR Newswire
Mar-19-19 12:28PM  Aerie (AERI) Starts Phase II Study on Eye Candidate AR-1105 Zacks
Mar-18-19 11:26AM  Karyopharm Stock Up Even as FDA Delays Selinexor NDA Verdict Zacks
Mar-12-19 09:50AM  Should Value Investors Consider Lannett Company (LCI) Now? Zacks
Mar-11-19 12:44PM  Lannett Rises After Announcing Adderall Distribution Agreement TheStreet.com
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as antibiotic, anti-psychosis, cardiovascular, central nervous system, gallstone, gastrointestinal, glaucoma, migraine, muscle relaxant, pain management, respiratory, thyroid deficiency, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Verapamil SR tablets, Ursodiol capsules, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Dicyclomine tablets and capsules, Metolazone tablets, and Methylphenidate Hydrochloride ER, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Pharm Group, Andor Pharmaceuticals LLC, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PAONESSA ALBERT IIIDirectorSep 09Sale12.5416,195203,08545,945Sep 11 04:15 PM
PAONESSA ALBERT IIIDirectorSep 06Sale10.3011,582119,29562,140Sep 06 04:16 PM
LEPORE PATRICK GDirectorSep 03Buy9.8225,000245,500201,340Sep 05 04:15 PM
Crew Timothy CChief Executive OfficerAug 29Buy8.452,00016,900183,884Sep 03 04:15 PM
FARBER JEFFREYDirectorMay 15Buy5.805,00029,0002,101,054May 15 04:14 PM
Crew Timothy CChief Executive OfficerMay 10Buy6.853,00020,55050,758May 10 04:10 PM
FARBER JEFFREYDirectorMay 09Buy6.8510,00068,5002,096,054May 09 04:19 PM
LEPORE PATRICK GDirectorMay 08Buy7.3225,000183,000142,895May 09 04:21 PM
Crew Timothy CChief Executive OfficerFeb 11Buy8.484,00033,92045,988Feb 11 04:31 PM
Chapman John CDirectorDec 14Buy4.9310,00049,30012,574Dec 17 04:20 PM
LEPORE PATRICK GDirectorDec 13Buy5.1025,000127,50092,895Dec 17 11:14 AM
PAONESSA ALBERT IIIDirectorDec 13Buy5.0710,00050,70040,277Dec 14 11:25 AM
FARBER JEFFREYDirectorDec 12Buy5.3210,00053,2002,086,054Dec 14 11:22 AM
Crew Timothy CChief Executive OfficerNov 09Buy5.352,00010,70041,988Nov 13 08:55 AM